Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 47,405,000 | 48,988,000 | 44,736,000 | 32,294,000 | 29,024,000 |
| Cost of Goods | 7,232,000 | 6,391,000 | 9,589,000 | 4,014,000 | 3,823,000 |
| Gross Profit | 40,173,000 | 42,597,000 | 35,147,000 | 28,280,000 | 25,201,000 |
| Operating Expenses | 28,976,000 | 28,391,000 | 30,892,000 | 16,689,000 | 15,312,000 |
| Operating Income | 11,197,000 | 14,206,000 | 4,255,000 | 11,591,000 | 9,889,000 |
| Other Income | -397,000 | -803,000 | -1,009,000 | 175,000 | 95,000 |
| Pre-tax Income | 10,800,000 | 13,403,000 | 3,246,000 | 11,766,000 | 9,984,000 |
| Income Tax | 3,178,000 | 2,460,000 | 1,614,000 | 2,599,000 | 2,433,000 |
| Net Income Continuous | 7,610,000 | 10,936,000 | 1,629,000 | 9,161,000 | 7,537,000 |
| Net Income Discontinuous | 498,000 | 425,000 | 2,311,000 | 375,000 | 251,000 |
| Net Income | $8,085,000 | $11,361,000 | $3,910,000 | $9,126,000 | $7,788,000 |
| EPS Basic Total Ops | 1.10 | 1.51 | 0.54 | 1.48 | 1.25 |
| EPS Basic Continuous Ops | 1.03 | 1.45 | 0.22 | 1.49 | 1.21 |
| EPS Basic Discontinuous Ops | 0.07 | 0.06 | 0.32 | 0.06 | 0.04 |
| EPS Diluted Total Ops | 1.09 | 1.49 | 0.54 | 1.46 | 1.22 |
| EPS Diluted Continuous Ops | 1.02 | 1.43 | 0.22 | 1.47 | 1.18 |
| EPS Diluted Discontinuous Ops | 0.07 | 0.06 | 0.32 | 0.06 | 0.04 |
| EBITDA(a) | $16,773,000 | $19,299,000 | $8,280,000 | $12,621,000 | $10,861,000 |